Therapy-Related Myelodysplastic Syndrome Recruiting Phase 1 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0079186 (Therapy-Related Myelodysplastic Syndrome)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs